Literature DB >> 17670832

Serine/arginine-rich proteins contribute to negative regulator of splicing element-stimulated polyadenylation in rous sarcoma virus.

Nicole L Maciolek1, Mark T McNally.   

Abstract

Rous sarcoma virus (RSV) requires large amounts of unspliced RNA for replication. Splicing and polyadenylation are coupled in the cells they infect, which raises the question of how viral RNA is efficiently polyadenylated in the absence of splicing. Optimal RSV polyadenylation requires a far-upstream splicing control element, the negative regulator of splicing (NRS), that binds SR proteins and U1/U11 snRNPs and functions as a pseudo-5' splice site that interacts with and sequesters 3' splice sites. We investigated a link between NRS-mediated splicing inhibition and efficient polyadenylation. In vitro, the NRS alone activated a model RSV polyadenylation substrate, and while the effect did not require the snRNP-binding sites or a downstream 3' splice site, SR proteins were sufficient to stimulate polyadenylation. Consistent with this, SELEX-binding sites for the SR proteins ASF/SF2, 9G8, and SRp20 were able to stimulate polyadenylation when placed upstream of the RSV poly(A) site. In vivo, however, the SELEX sites improved polyadenylation in proviral clones only when the NRS-3' splice site complex could form. Deletions that positioned the SR protein-binding sites closer to the poly(A) site eliminated the requirement for the NRS-3' splice site interaction. This indicates a novel role for SR proteins in promoting RSV polyadenylation in the context of the NRS-3' splice site complex, which is thought to bridge the long distance between the NRS and poly(A) site. The results further suggest a more general role for SR proteins in polyadenylation of cellular mRNAs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17670832      PMCID: PMC2045511          DOI: 10.1128/JVI.00919-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  59 in total

1.  Solution structure of the pseudo-5' splice site of a retroviral splicing suppressor.

Authors:  Javier Cabello-Villegas; Keith E Giles; Ana Maria Soto; Ping Yu; Annie Mougin; Karen L Beemon; Yun-Xing Wang
Journal:  RNA       Date:  2004-09       Impact factor: 4.942

2.  In vitro polyadenylation is stimulated by the presence of an upstream intron.

Authors:  M Niwa; S D Rose; S M Berget
Journal:  Genes Dev       Date:  1990-09       Impact factor: 11.361

3.  Two-step affinity purification of U7 small nuclear ribonucleoprotein particles using complementary biotinylated 2'-O-methyl oligoribonucleotides.

Authors:  H O Smith; K Tabiti; G Schaffner; D Soldati; U Albrecht; M L Birnstiel
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

4.  The role of branchpoint and 3'-exon sequences in the control of balanced splicing of avian retrovirus RNA.

Authors:  X D Fu; R A Katz; A M Skalka; T Maniatis
Journal:  Genes Dev       Date:  1991-02       Impact factor: 11.361

5.  Control of retroviral RNA splicing through maintenance of suboptimal processing signals.

Authors:  R A Katz; A M Skalka
Journal:  Mol Cell Biol       Date:  1990-02       Impact factor: 4.272

6.  Multiple regions in the Rous sarcoma virus src gene intron act in cis to affect the accumulation of unspliced RNA.

Authors:  C M Stoltzfus; S J Fogarty
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

7.  Rous sarcoma virus negative regulator of splicing selectively suppresses SRC mRNA splicing and promotes polyadenylation.

Authors:  Christopher T O'Sullivan; Tatjana S Polony; Robert E Paca; Karen L Beemon
Journal:  Virology       Date:  2002-10-25       Impact factor: 3.616

8.  Intronic sequences and 3' splice sites control Rous sarcoma virus RNA splicing.

Authors:  M T McNally; K Beemon
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

9.  Distinct sequence motifs within the 68-kDa subunit of cleavage factor Im mediate RNA binding, protein-protein interactions, and subcellular localization.

Authors:  Sabine Dettwiler; Chiara Aringhieri; Stefano Cardinale; Walter Keller; Silvia M L Barabino
Journal:  J Biol Chem       Date:  2004-05-28       Impact factor: 5.157

10.  An evolutionarily conserved role for SRm160 in 3'-end processing that functions independently of exon junction complex formation.

Authors:  Susan McCracken; Dasa Longman; Iain L Johnstone; Javier F Cáceres; Benjamin J Blencowe
Journal:  J Biol Chem       Date:  2003-08-27       Impact factor: 5.157

View more
  20 in total

1.  Inhibition of HIV-1 replication by eIF3f.

Authors:  Susana T Valente; Greg M Gilmartin; Christina Mott; Brie Falkard; Stephen P Goff
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-23       Impact factor: 11.205

2.  Genes involved in pre-mRNA 3'-end formation and transcription termination revealed by a lin-15 operon Muv suppressor screen.

Authors:  Mingxue Cui; Mary Ann Allen; Alison Larsen; Margaret Macmorris; Min Han; Tom Blumenthal
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-22       Impact factor: 11.205

Review 3.  RNA processing control in avian retroviruses.

Authors:  Mark T McNally
Journal:  Front Biosci       Date:  2008-05-01

4.  Polypyrimidine tract binding protein prevents activity of an intronic regulatory element that promotes usage of a composite 3'-terminal exon.

Authors:  Vincent Anquetil; Caroline Le Sommer; Agnès Méreau; Sandra Hamon; Hubert Lerivray; Serge Hardy
Journal:  J Biol Chem       Date:  2009-09-17       Impact factor: 5.157

5.  Evidence that a threshold of serine/arginine-rich (SR) proteins recruits CFIm to promote rous sarcoma virus mRNA 3' end formation.

Authors:  Stephen W Hudson; Lisa M McNally; Mark T McNally
Journal:  Virology       Date:  2016-09-04       Impact factor: 3.616

6.  Juxtaposition of two distant, serine-arginine-rich protein-binding elements is required for optimal polyadenylation in Rous sarcoma virus.

Authors:  Stephen W Hudson; Mark T McNally
Journal:  J Virol       Date:  2011-08-17       Impact factor: 5.103

7.  Characterization of Rous sarcoma virus polyadenylation site use in vitro.

Authors:  Nicole L Maciolek; Mark T McNally
Journal:  Virology       Date:  2008-02-13       Impact factor: 3.616

8.  HIV-1 mRNA 3' end processing is distinctively regulated by eIF3f, CDK11, and splice factor 9G8.

Authors:  Susana T Valente; Greg M Gilmartin; Krishnan Venkatarama; Gloria Arriagada; Stephen P Goff
Journal:  Mol Cell       Date:  2009-10-23       Impact factor: 17.970

9.  Control of the papillomavirus early-to-late switch by differentially expressed SRp20.

Authors:  Rong Jia; Xuefeng Liu; Mingfang Tao; Michael Kruhlak; Ming Guo; Craig Meyers; Carl C Baker; Zhi-Ming Zheng
Journal:  J Virol       Date:  2008-10-22       Impact factor: 5.103

Review 10.  Molecular mechanisms of eukaryotic pre-mRNA 3' end processing regulation.

Authors:  Stefania Millevoi; Stéphan Vagner
Journal:  Nucleic Acids Res       Date:  2009-12-30       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.